nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoclopramide—CYP17A1—seminiferous tubule of testis—testicular cancer	0.169	0.715	CbGeAlD
Metoclopramide—Sunitinib—STK11—testicular cancer	0.0304	0.437	CrCbGaD
Metoclopramide—Sunitinib—STK10—testicular cancer	0.0289	0.415	CrCbGaD
Metoclopramide—CYP17A1—gonad—testicular cancer	0.0143	0.0606	CbGeAlD
Metoclopramide—CYP11B2—lymph node—testicular cancer	0.0123	0.0518	CbGeAlD
Metoclopramide—CYP17A1—female gonad—testicular cancer	0.0117	0.0492	CbGeAlD
Metoclopramide—Sunitinib—KIT—testicular cancer	0.0103	0.149	CrCbGaD
Metoclopramide—CYP17A1—testis—testicular cancer	0.0103	0.0437	CbGeAlD
Metoclopramide—CYP17A1—lymph node—testicular cancer	0.00749	0.0316	CbGeAlD
Metoclopramide—DRD2—testis—testicular cancer	0.00496	0.021	CbGeAlD
Metoclopramide—Tremor—Chlorambucil—testicular cancer	0.00384	0.00553	CcSEcCtD
Metoclopramide—Bronchospasm—Ifosfamide—testicular cancer	0.00383	0.00551	CcSEcCtD
Metoclopramide—Hepatotoxicity—Methotrexate—testicular cancer	0.0038	0.00548	CcSEcCtD
Metoclopramide—Agitation—Chlorambucil—testicular cancer	0.00376	0.00543	CcSEcCtD
Metoclopramide—Angioedema—Chlorambucil—testicular cancer	0.00374	0.0054	CcSEcCtD
Metoclopramide—Leukopenia—Chlorambucil—testicular cancer	0.00367	0.00529	CcSEcCtD
Metoclopramide—Pollakiuria—Ifosfamide—testicular cancer	0.00359	0.00518	CcSEcCtD
Metoclopramide—Convulsion—Chlorambucil—testicular cancer	0.00355	0.00512	CcSEcCtD
Metoclopramide—Agranulocytosis—Dactinomycin—testicular cancer	0.00353	0.00509	CcSEcCtD
Metoclopramide—Flushing—Bleomycin—testicular cancer	0.00338	0.00487	CcSEcCtD
Metoclopramide—Cardiac arrest—Etoposide—testicular cancer	0.00338	0.00487	CcSEcCtD
Metoclopramide—Confusional state—Chlorambucil—testicular cancer	0.00337	0.00486	CcSEcCtD
Metoclopramide—CYP2D6—female gonad—testicular cancer	0.00336	0.0142	CbGeAlD
Metoclopramide—Leukopenia—Vinblastine—testicular cancer	0.00336	0.00484	CcSEcCtD
Metoclopramide—Blood disorder—Epirubicin—testicular cancer	0.00329	0.00474	CcSEcCtD
Metoclopramide—Convulsion—Vinblastine—testicular cancer	0.00325	0.00469	CcSEcCtD
Metoclopramide—Hypertension—Vinblastine—testicular cancer	0.00324	0.00467	CcSEcCtD
Metoclopramide—Agranulocytosis—Ifosfamide—testicular cancer	0.00324	0.00467	CcSEcCtD
Metoclopramide—Delirium—Epirubicin—testicular cancer	0.00319	0.0046	CcSEcCtD
Metoclopramide—Bradycardia—Ifosfamide—testicular cancer	0.00317	0.00457	CcSEcCtD
Metoclopramide—Flushing—Dactinomycin—testicular cancer	0.00315	0.00455	CcSEcCtD
Metoclopramide—Amenorrhoea—Epirubicin—testicular cancer	0.00312	0.0045	CcSEcCtD
Metoclopramide—Hallucination—Ifosfamide—testicular cancer	0.0031	0.00447	CcSEcCtD
Metoclopramide—Blood disorder—Doxorubicin—testicular cancer	0.00304	0.00438	CcSEcCtD
Metoclopramide—Bronchospasm—Etoposide—testicular cancer	0.00302	0.00436	CcSEcCtD
Metoclopramide—Visual impairment—Ifosfamide—testicular cancer	0.003	0.00432	CcSEcCtD
Metoclopramide—Respiratory failure—Methotrexate—testicular cancer	0.00299	0.00431	CcSEcCtD
Metoclopramide—CYP2D6—testis—testicular cancer	0.00298	0.0126	CbGeAlD
Metoclopramide—Delirium—Doxorubicin—testicular cancer	0.00295	0.00426	CcSEcCtD
Metoclopramide—Dyskinesia—Epirubicin—testicular cancer	0.00292	0.00421	CcSEcCtD
Metoclopramide—Amenorrhoea—Doxorubicin—testicular cancer	0.00289	0.00417	CcSEcCtD
Metoclopramide—Flushing—Ifosfamide—testicular cancer	0.00289	0.00416	CcSEcCtD
Metoclopramide—Fatigue—Chlorambucil—testicular cancer	0.00288	0.00416	CcSEcCtD
Metoclopramide—Neutropenia—Etoposide—testicular cancer	0.00287	0.00414	CcSEcCtD
Metoclopramide—Leukopenia—Bleomycin—testicular cancer	0.00284	0.00409	CcSEcCtD
Metoclopramide—Atrioventricular block—Epirubicin—testicular cancer	0.00283	0.00408	CcSEcCtD
Metoclopramide—Feeling abnormal—Chlorambucil—testicular cancer	0.00275	0.00397	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Epirubicin—testicular cancer	0.00274	0.00396	CcSEcCtD
Metoclopramide—Bradycardia—Cisplatin—testicular cancer	0.00273	0.00394	CcSEcCtD
Metoclopramide—Dyskinesia—Doxorubicin—testicular cancer	0.0027	0.0039	CcSEcCtD
Metoclopramide—Jaundice—Etoposide—testicular cancer	0.00267	0.00385	CcSEcCtD
Metoclopramide—Urticaria—Chlorambucil—testicular cancer	0.00266	0.00383	CcSEcCtD
Metoclopramide—Leukopenia—Dactinomycin—testicular cancer	0.00265	0.00382	CcSEcCtD
Metoclopramide—Body temperature increased—Chlorambucil—testicular cancer	0.00264	0.00381	CcSEcCtD
Metoclopramide—Gynaecomastia—Methotrexate—testicular cancer	0.00262	0.00378	CcSEcCtD
Metoclopramide—Atrioventricular block—Doxorubicin—testicular cancer	0.00262	0.00377	CcSEcCtD
Metoclopramide—Confusional state—Bleomycin—testicular cancer	0.00261	0.00376	CcSEcCtD
Metoclopramide—Fluid retention—Epirubicin—testicular cancer	0.00261	0.00376	CcSEcCtD
Metoclopramide—Oedema—Bleomycin—testicular cancer	0.00259	0.00373	CcSEcCtD
Metoclopramide—Visual impairment—Cisplatin—testicular cancer	0.00259	0.00373	CcSEcCtD
Metoclopramide—Agranulocytosis—Etoposide—testicular cancer	0.00256	0.00368	CcSEcCtD
Metoclopramide—Ventricular tachycardia—Doxorubicin—testicular cancer	0.00254	0.00366	CcSEcCtD
Metoclopramide—Feeling abnormal—Vinblastine—testicular cancer	0.00252	0.00364	CcSEcCtD
Metoclopramide—Rash maculo-papular—Epirubicin—testicular cancer	0.00249	0.0036	CcSEcCtD
Metoclopramide—Flushing—Cisplatin—testicular cancer	0.00249	0.00359	CcSEcCtD
Metoclopramide—Agitation—Ifosfamide—testicular cancer	0.00249	0.00359	CcSEcCtD
Metoclopramide—Angioedema—Ifosfamide—testicular cancer	0.00248	0.00357	CcSEcCtD
Metoclopramide—Hypersensitivity—Chlorambucil—testicular cancer	0.00246	0.00355	CcSEcCtD
Metoclopramide—Leukopenia—Ifosfamide—testicular cancer	0.00243	0.0035	CcSEcCtD
Metoclopramide—Hypotension—Bleomycin—testicular cancer	0.00242	0.00349	CcSEcCtD
Metoclopramide—Oedema—Dactinomycin—testicular cancer	0.00241	0.00348	CcSEcCtD
Metoclopramide—Fluid retention—Doxorubicin—testicular cancer	0.00241	0.00348	CcSEcCtD
Metoclopramide—Asthenia—Chlorambucil—testicular cancer	0.0024	0.00346	CcSEcCtD
Metoclopramide—Palpitations—Ifosfamide—testicular cancer	0.00239	0.00345	CcSEcCtD
Metoclopramide—Convulsion—Ifosfamide—testicular cancer	0.00235	0.00338	CcSEcCtD
Metoclopramide—Hypertension—Ifosfamide—testicular cancer	0.00234	0.00337	CcSEcCtD
Metoclopramide—Rash maculo-papular—Doxorubicin—testicular cancer	0.00231	0.00333	CcSEcCtD
Metoclopramide—Dyspnoea—Bleomycin—testicular cancer	0.00231	0.00333	CcSEcCtD
Metoclopramide—Diarrhoea—Chlorambucil—testicular cancer	0.00229	0.0033	CcSEcCtD
Metoclopramide—Flushing—Etoposide—testicular cancer	0.00228	0.00329	CcSEcCtD
Metoclopramide—Hypersensitivity—Vinblastine—testicular cancer	0.00226	0.00325	CcSEcCtD
Metoclopramide—Visual disturbance—Methotrexate—testicular cancer	0.00225	0.00324	CcSEcCtD
Metoclopramide—Muscle spasms—Cisplatin—testicular cancer	0.00225	0.00324	CcSEcCtD
Metoclopramide—Confusional state—Ifosfamide—testicular cancer	0.00223	0.00321	CcSEcCtD
Metoclopramide—Oedema—Ifosfamide—testicular cancer	0.00221	0.00319	CcSEcCtD
Metoclopramide—Asthenia—Vinblastine—testicular cancer	0.0022	0.00317	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Epirubicin—testicular cancer	0.0022	0.00317	CcSEcCtD
Metoclopramide—Tremor—Cisplatin—testicular cancer	0.00219	0.00316	CcSEcCtD
Metoclopramide—Feeling abnormal—Bleomycin—testicular cancer	0.00213	0.00307	CcSEcCtD
Metoclopramide—Diarrhoea—Vinblastine—testicular cancer	0.0021	0.00302	CcSEcCtD
Metoclopramide—Renal impairment—Epirubicin—testicular cancer	0.00209	0.00302	CcSEcCtD
Metoclopramide—Leukopenia—Cisplatin—testicular cancer	0.00209	0.00301	CcSEcCtD
Metoclopramide—Fatigue—Dactinomycin—testicular cancer	0.00208	0.003	CcSEcCtD
Metoclopramide—Hypotension—Ifosfamide—testicular cancer	0.00207	0.00298	CcSEcCtD
Metoclopramide—Muscle spasms—Etoposide—testicular cancer	0.00206	0.00297	CcSEcCtD
Metoclopramide—Urticaria—Bleomycin—testicular cancer	0.00206	0.00296	CcSEcCtD
Metoclopramide—Body temperature increased—Bleomycin—testicular cancer	0.00205	0.00295	CcSEcCtD
Metoclopramide—Cardiac failure congestive—Doxorubicin—testicular cancer	0.00203	0.00293	CcSEcCtD
Metoclopramide—Dizziness—Vinblastine—testicular cancer	0.00203	0.00292	CcSEcCtD
Metoclopramide—Convulsion—Cisplatin—testicular cancer	0.00202	0.00292	CcSEcCtD
Metoclopramide—Feeling abnormal—Dactinomycin—testicular cancer	0.00199	0.00287	CcSEcCtD
Metoclopramide—Nausea—Chlorambucil—testicular cancer	0.00199	0.00286	CcSEcCtD
Metoclopramide—Anxiety—Cisplatin—testicular cancer	0.00198	0.00286	CcSEcCtD
Metoclopramide—Dyspnoea—Ifosfamide—testicular cancer	0.00197	0.00284	CcSEcCtD
Metoclopramide—Somnolence—Ifosfamide—testicular cancer	0.00197	0.00283	CcSEcCtD
Metoclopramide—Renal impairment—Doxorubicin—testicular cancer	0.00194	0.00279	CcSEcCtD
Metoclopramide—Headache—Vinblastine—testicular cancer	0.00192	0.00277	CcSEcCtD
Metoclopramide—Leukopenia—Etoposide—testicular cancer	0.00192	0.00276	CcSEcCtD
Metoclopramide—Body temperature increased—Dactinomycin—testicular cancer	0.00191	0.00275	CcSEcCtD
Metoclopramide—Fatigue—Ifosfamide—testicular cancer	0.00191	0.00275	CcSEcCtD
Metoclopramide—Oedema—Cisplatin—testicular cancer	0.00191	0.00275	CcSEcCtD
Metoclopramide—Hypersensitivity—Bleomycin—testicular cancer	0.00191	0.00275	CcSEcCtD
Metoclopramide—Cardiac arrest—Epirubicin—testicular cancer	0.00189	0.00273	CcSEcCtD
Metoclopramide—Tachycardia—Cisplatin—testicular cancer	0.00186	0.00268	CcSEcCtD
Metoclopramide—Asthenia—Bleomycin—testicular cancer	0.00186	0.00268	CcSEcCtD
Metoclopramide—Convulsion—Etoposide—testicular cancer	0.00185	0.00267	CcSEcCtD
Metoclopramide—Hypertension—Etoposide—testicular cancer	0.00185	0.00266	CcSEcCtD
Metoclopramide—Asthma—Methotrexate—testicular cancer	0.00184	0.00265	CcSEcCtD
Metoclopramide—Feeling abnormal—Ifosfamide—testicular cancer	0.00182	0.00263	CcSEcCtD
Metoclopramide—Nausea—Vinblastine—testicular cancer	0.00182	0.00262	CcSEcCtD
Metoclopramide—Hypotension—Cisplatin—testicular cancer	0.00178	0.00257	CcSEcCtD
Metoclopramide—Hypersensitivity—Dactinomycin—testicular cancer	0.00178	0.00256	CcSEcCtD
Metoclopramide—Confusional state—Etoposide—testicular cancer	0.00176	0.00254	CcSEcCtD
Metoclopramide—Urticaria—Ifosfamide—testicular cancer	0.00176	0.00253	CcSEcCtD
Metoclopramide—Cardiac arrest—Doxorubicin—testicular cancer	0.00175	0.00253	CcSEcCtD
Metoclopramide—Body temperature increased—Ifosfamide—testicular cancer	0.00175	0.00252	CcSEcCtD
Metoclopramide—Asthenia—Dactinomycin—testicular cancer	0.00173	0.0025	CcSEcCtD
Metoclopramide—Asthma—Epirubicin—testicular cancer	0.00172	0.00248	CcSEcCtD
Metoclopramide—Neutropenia—Methotrexate—testicular cancer	0.00172	0.00248	CcSEcCtD
Metoclopramide—Tachycardia—Etoposide—testicular cancer	0.0017	0.00246	CcSEcCtD
Metoclopramide—Dyspnoea—Cisplatin—testicular cancer	0.0017	0.00245	CcSEcCtD
Metoclopramide—Erectile dysfunction—Methotrexate—testicular cancer	0.00169	0.00244	CcSEcCtD
Metoclopramide—Diarrhoea—Dactinomycin—testicular cancer	0.00165	0.00238	CcSEcCtD
Metoclopramide—Drowsiness—Methotrexate—testicular cancer	0.00164	0.00236	CcSEcCtD
Metoclopramide—Depression—Methotrexate—testicular cancer	0.00164	0.00236	CcSEcCtD
Metoclopramide—Hypotension—Etoposide—testicular cancer	0.00163	0.00235	CcSEcCtD
Metoclopramide—Rash—Bleomycin—testicular cancer	0.00163	0.00235	CcSEcCtD
Metoclopramide—Dermatitis—Bleomycin—testicular cancer	0.00163	0.00235	CcSEcCtD
Metoclopramide—Hypersensitivity—Ifosfamide—testicular cancer	0.00163	0.00235	CcSEcCtD
Metoclopramide—Neutropenia—Epirubicin—testicular cancer	0.00161	0.00232	CcSEcCtD
Metoclopramide—Asthma—Doxorubicin—testicular cancer	0.00159	0.0023	CcSEcCtD
Metoclopramide—Pollakiuria—Epirubicin—testicular cancer	0.00159	0.00229	CcSEcCtD
Metoclopramide—Asthenia—Ifosfamide—testicular cancer	0.00159	0.00229	CcSEcCtD
Metoclopramide—Feeling abnormal—Cisplatin—testicular cancer	0.00157	0.00227	CcSEcCtD
Metoclopramide—Dyspnoea—Etoposide—testicular cancer	0.00156	0.00225	CcSEcCtD
Metoclopramide—Somnolence—Etoposide—testicular cancer	0.00155	0.00224	CcSEcCtD
Metoclopramide—Nausea—Bleomycin—testicular cancer	0.00154	0.00222	CcSEcCtD
Metoclopramide—Drowsiness—Epirubicin—testicular cancer	0.00154	0.00221	CcSEcCtD
Metoclopramide—Agranulocytosis—Methotrexate—testicular cancer	0.00153	0.00221	CcSEcCtD
Metoclopramide—Rash—Dactinomycin—testicular cancer	0.00152	0.00219	CcSEcCtD
Metoclopramide—Diarrhoea—Ifosfamide—testicular cancer	0.00151	0.00218	CcSEcCtD
Metoclopramide—Body temperature increased—Cisplatin—testicular cancer	0.00151	0.00217	CcSEcCtD
Metoclopramide—Fatigue—Etoposide—testicular cancer	0.00151	0.00217	CcSEcCtD
Metoclopramide—Jaundice—Epirubicin—testicular cancer	0.0015	0.00216	CcSEcCtD
Metoclopramide—Neutropenia—Doxorubicin—testicular cancer	0.00149	0.00215	CcSEcCtD
Metoclopramide—Pollakiuria—Doxorubicin—testicular cancer	0.00147	0.00212	CcSEcCtD
Metoclopramide—Dizziness—Ifosfamide—testicular cancer	0.00146	0.00211	CcSEcCtD
Metoclopramide—Feeling abnormal—Etoposide—testicular cancer	0.00144	0.00208	CcSEcCtD
Metoclopramide—Nausea—Dactinomycin—testicular cancer	0.00143	0.00207	CcSEcCtD
Metoclopramide—Agranulocytosis—Epirubicin—testicular cancer	0.00143	0.00207	CcSEcCtD
Metoclopramide—Drowsiness—Doxorubicin—testicular cancer	0.00142	0.00205	CcSEcCtD
Metoclopramide—Visual impairment—Methotrexate—testicular cancer	0.00142	0.00205	CcSEcCtD
Metoclopramide—Hypersensitivity—Cisplatin—testicular cancer	0.0014	0.00203	CcSEcCtD
Metoclopramide—Bradycardia—Epirubicin—testicular cancer	0.0014	0.00202	CcSEcCtD
Metoclopramide—Rash—Ifosfamide—testicular cancer	0.00139	0.00201	CcSEcCtD
Metoclopramide—Dermatitis—Ifosfamide—testicular cancer	0.00139	0.00201	CcSEcCtD
Metoclopramide—Urticaria—Etoposide—testicular cancer	0.00139	0.002	CcSEcCtD
Metoclopramide—Jaundice—Doxorubicin—testicular cancer	0.00138	0.002	CcSEcCtD
Metoclopramide—Body temperature increased—Etoposide—testicular cancer	0.00138	0.00199	CcSEcCtD
Metoclopramide—Asthenia—Cisplatin—testicular cancer	0.00137	0.00197	CcSEcCtD
Metoclopramide—Visual impairment—Epirubicin—testicular cancer	0.00133	0.00191	CcSEcCtD
Metoclopramide—Agranulocytosis—Doxorubicin—testicular cancer	0.00133	0.00191	CcSEcCtD
Metoclopramide—Nausea—Ifosfamide—testicular cancer	0.00131	0.00189	CcSEcCtD
Metoclopramide—Diarrhoea—Cisplatin—testicular cancer	0.0013	0.00188	CcSEcCtD
Metoclopramide—Bradycardia—Doxorubicin—testicular cancer	0.0013	0.00187	CcSEcCtD
Metoclopramide—Hypersensitivity—Etoposide—testicular cancer	0.00129	0.00186	CcSEcCtD
Metoclopramide—Flushing—Epirubicin—testicular cancer	0.00128	0.00184	CcSEcCtD
Metoclopramide—Asthenia—Etoposide—testicular cancer	0.00125	0.00181	CcSEcCtD
Metoclopramide—Visual impairment—Doxorubicin—testicular cancer	0.00123	0.00177	CcSEcCtD
Metoclopramide—Rash—Cisplatin—testicular cancer	0.0012	0.00173	CcSEcCtD
Metoclopramide—Dermatitis—Cisplatin—testicular cancer	0.0012	0.00173	CcSEcCtD
Metoclopramide—Diarrhoea—Etoposide—testicular cancer	0.0012	0.00172	CcSEcCtD
Metoclopramide—Flushing—Doxorubicin—testicular cancer	0.00118	0.00171	CcSEcCtD
Metoclopramide—Nervousness—Epirubicin—testicular cancer	0.00117	0.00168	CcSEcCtD
Metoclopramide—Dizziness—Etoposide—testicular cancer	0.00115	0.00167	CcSEcCtD
Metoclopramide—Muscle spasms—Epirubicin—testicular cancer	0.00115	0.00166	CcSEcCtD
Metoclopramide—Leukopenia—Methotrexate—testicular cancer	0.00115	0.00165	CcSEcCtD
Metoclopramide—Nausea—Cisplatin—testicular cancer	0.00113	0.00163	CcSEcCtD
Metoclopramide—Convulsion—Methotrexate—testicular cancer	0.00111	0.0016	CcSEcCtD
Metoclopramide—Agitation—Epirubicin—testicular cancer	0.0011	0.00159	CcSEcCtD
Metoclopramide—Rash—Etoposide—testicular cancer	0.0011	0.00159	CcSEcCtD
Metoclopramide—Dermatitis—Etoposide—testicular cancer	0.0011	0.00159	CcSEcCtD
Metoclopramide—Headache—Etoposide—testicular cancer	0.00109	0.00158	CcSEcCtD
Metoclopramide—Nervousness—Doxorubicin—testicular cancer	0.00108	0.00155	CcSEcCtD
Metoclopramide—Leukopenia—Epirubicin—testicular cancer	0.00107	0.00155	CcSEcCtD
Metoclopramide—Muscle spasms—Doxorubicin—testicular cancer	0.00107	0.00154	CcSEcCtD
Metoclopramide—Palpitations—Epirubicin—testicular cancer	0.00106	0.00153	CcSEcCtD
Metoclopramide—Confusional state—Methotrexate—testicular cancer	0.00105	0.00152	CcSEcCtD
Metoclopramide—Convulsion—Epirubicin—testicular cancer	0.00104	0.0015	CcSEcCtD
Metoclopramide—Nausea—Etoposide—testicular cancer	0.00104	0.0015	CcSEcCtD
Metoclopramide—Hypertension—Epirubicin—testicular cancer	0.00104	0.00149	CcSEcCtD
Metoclopramide—Agitation—Doxorubicin—testicular cancer	0.00102	0.00147	CcSEcCtD
Metoclopramide—Anxiety—Epirubicin—testicular cancer	0.00102	0.00147	CcSEcCtD
Metoclopramide—Leukopenia—Doxorubicin—testicular cancer	0.000994	0.00143	CcSEcCtD
Metoclopramide—Confusional state—Epirubicin—testicular cancer	0.000987	0.00142	CcSEcCtD
Metoclopramide—Palpitations—Doxorubicin—testicular cancer	0.000981	0.00141	CcSEcCtD
Metoclopramide—Oedema—Epirubicin—testicular cancer	0.000979	0.00141	CcSEcCtD
Metoclopramide—Hypotension—Methotrexate—testicular cancer	0.000978	0.00141	CcSEcCtD
Metoclopramide—Convulsion—Doxorubicin—testicular cancer	0.000962	0.00139	CcSEcCtD
Metoclopramide—Hypertension—Doxorubicin—testicular cancer	0.000958	0.00138	CcSEcCtD
Metoclopramide—Tachycardia—Epirubicin—testicular cancer	0.000956	0.00138	CcSEcCtD
Metoclopramide—Insomnia—Methotrexate—testicular cancer	0.000946	0.00136	CcSEcCtD
Metoclopramide—Anxiety—Doxorubicin—testicular cancer	0.000942	0.00136	CcSEcCtD
Metoclopramide—Dyspnoea—Methotrexate—testicular cancer	0.000933	0.00134	CcSEcCtD
Metoclopramide—Somnolence—Methotrexate—testicular cancer	0.00093	0.00134	CcSEcCtD
Metoclopramide—Hypotension—Epirubicin—testicular cancer	0.000915	0.00132	CcSEcCtD
Metoclopramide—Confusional state—Doxorubicin—testicular cancer	0.000913	0.00132	CcSEcCtD
Metoclopramide—Oedema—Doxorubicin—testicular cancer	0.000906	0.00131	CcSEcCtD
Metoclopramide—Fatigue—Methotrexate—testicular cancer	0.000902	0.0013	CcSEcCtD
Metoclopramide—Insomnia—Epirubicin—testicular cancer	0.000885	0.00128	CcSEcCtD
Metoclopramide—Tachycardia—Doxorubicin—testicular cancer	0.000884	0.00127	CcSEcCtD
Metoclopramide—Dyspnoea—Epirubicin—testicular cancer	0.000873	0.00126	CcSEcCtD
Metoclopramide—Somnolence—Epirubicin—testicular cancer	0.00087	0.00125	CcSEcCtD
Metoclopramide—Feeling abnormal—Methotrexate—testicular cancer	0.000862	0.00124	CcSEcCtD
Metoclopramide—Hypotension—Doxorubicin—testicular cancer	0.000846	0.00122	CcSEcCtD
Metoclopramide—Fatigue—Epirubicin—testicular cancer	0.000844	0.00122	CcSEcCtD
Metoclopramide—Urticaria—Methotrexate—testicular cancer	0.000831	0.0012	CcSEcCtD
Metoclopramide—Body temperature increased—Methotrexate—testicular cancer	0.000827	0.00119	CcSEcCtD
Metoclopramide—Insomnia—Doxorubicin—testicular cancer	0.000819	0.00118	CcSEcCtD
Metoclopramide—Dyspnoea—Doxorubicin—testicular cancer	0.000808	0.00116	CcSEcCtD
Metoclopramide—Feeling abnormal—Epirubicin—testicular cancer	0.000807	0.00116	CcSEcCtD
Metoclopramide—Somnolence—Doxorubicin—testicular cancer	0.000805	0.00116	CcSEcCtD
Metoclopramide—Fatigue—Doxorubicin—testicular cancer	0.000781	0.00113	CcSEcCtD
Metoclopramide—Urticaria—Epirubicin—testicular cancer	0.000778	0.00112	CcSEcCtD
Metoclopramide—Body temperature increased—Epirubicin—testicular cancer	0.000774	0.00112	CcSEcCtD
Metoclopramide—Hypersensitivity—Methotrexate—testicular cancer	0.000771	0.00111	CcSEcCtD
Metoclopramide—Asthenia—Methotrexate—testicular cancer	0.000751	0.00108	CcSEcCtD
Metoclopramide—Feeling abnormal—Doxorubicin—testicular cancer	0.000746	0.00108	CcSEcCtD
Metoclopramide—Hypersensitivity—Epirubicin—testicular cancer	0.000721	0.00104	CcSEcCtD
Metoclopramide—Urticaria—Doxorubicin—testicular cancer	0.00072	0.00104	CcSEcCtD
Metoclopramide—Body temperature increased—Doxorubicin—testicular cancer	0.000716	0.00103	CcSEcCtD
Metoclopramide—Diarrhoea—Methotrexate—testicular cancer	0.000716	0.00103	CcSEcCtD
Metoclopramide—Asthenia—Epirubicin—testicular cancer	0.000702	0.00101	CcSEcCtD
Metoclopramide—Dizziness—Methotrexate—testicular cancer	0.000692	0.000997	CcSEcCtD
Metoclopramide—Diarrhoea—Epirubicin—testicular cancer	0.00067	0.000966	CcSEcCtD
Metoclopramide—Hypersensitivity—Doxorubicin—testicular cancer	0.000667	0.000962	CcSEcCtD
Metoclopramide—Rash—Methotrexate—testicular cancer	0.00066	0.000951	CcSEcCtD
Metoclopramide—Dermatitis—Methotrexate—testicular cancer	0.000659	0.00095	CcSEcCtD
Metoclopramide—Headache—Methotrexate—testicular cancer	0.000655	0.000945	CcSEcCtD
Metoclopramide—Asthenia—Doxorubicin—testicular cancer	0.00065	0.000937	CcSEcCtD
Metoclopramide—Dizziness—Epirubicin—testicular cancer	0.000647	0.000933	CcSEcCtD
Metoclopramide—Nausea—Methotrexate—testicular cancer	0.000621	0.000896	CcSEcCtD
Metoclopramide—Diarrhoea—Doxorubicin—testicular cancer	0.00062	0.000894	CcSEcCtD
Metoclopramide—Rash—Epirubicin—testicular cancer	0.000617	0.00089	CcSEcCtD
Metoclopramide—Dermatitis—Epirubicin—testicular cancer	0.000617	0.000889	CcSEcCtD
Metoclopramide—Headache—Epirubicin—testicular cancer	0.000613	0.000884	CcSEcCtD
Metoclopramide—Dizziness—Doxorubicin—testicular cancer	0.000599	0.000864	CcSEcCtD
Metoclopramide—Nausea—Epirubicin—testicular cancer	0.000582	0.000838	CcSEcCtD
Metoclopramide—Rash—Doxorubicin—testicular cancer	0.000571	0.000823	CcSEcCtD
Metoclopramide—Dermatitis—Doxorubicin—testicular cancer	0.000571	0.000823	CcSEcCtD
Metoclopramide—Headache—Doxorubicin—testicular cancer	0.000567	0.000818	CcSEcCtD
Metoclopramide—Nausea—Doxorubicin—testicular cancer	0.000538	0.000776	CcSEcCtD
